tradingkey.logo

Psyence Biomedical Ltd

PBM

4.710USD

+2.350+99.58%
Market hours ETQuotes delayed by 15 min
105.51KMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
Operating expenses
-31.11%176.16K
205.24%1.29M
--255.73K
--421.51K
R&D expenses
----
392.45%790.89K
--1.94K
--160.60K
Other operating expenses
---8.54K
--8.53K
----
----
Operating profit
31.11%-176.16K
-205.24%-1.29M
---255.73K
---421.51K
Net non-operating interest income (expenses)
Gains from sale of securities
-6771.05%-105.58K
-632.09%-9.90K
---1.54K
---1.35K
Other non-operating income (expenses)
---8.54K
--8.53K
----
----
Income before tax
-24.09%-318.21K
-204.59%-1.29M
---256.43K
---422.70K
Income after tax
-24.09%-318.21K
-204.59%-1.29M
---256.43K
---422.70K
Net income from continuous operations
-24.09%-318.21K
-204.59%-1.29M
---256.43K
---422.70K
Net income attributable to controlling interests
-24.09%-318.21K
-204.59%-1.29M
---256.43K
---422.70K
Net income attributable to common shareholders
-24.09%-318.21K
-204.59%-1.29M
---256.43K
---422.70K
Basic earnings per share
-24.07%-1.78
-204.56%-7.21
---1.44
---2.37
Diluted earnings per share
-24.07%-1.78
-204.56%-7.21
---1.44
---2.37
Dividend per share
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
KeyAI